Search reports.
UAE Artificial Organs & Bionic Implants Market Trends 2031
Get free sample report Request for Customiztion Buy Now

UAE Artificial Organs & Bionic Implants Market Trends 2031

Segments - UAE Artificial Organs & Bionic Implants Market by Product (Artificial Organs [Artificial Heart, Artificial Kidney, Cochlear Implants, and Others], Bionics [Vision Bionics, Ear Bionics, Orthopedic Bionic, Cardiac Bionics, and Others]) - UAE Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1539 | 4.8 Rating | 64 Reviews | 173 Pages | Format : PDF Excel PPT

Report Description


The UAE Artificial Organs & Bionic Implants Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 11.48% during the forecast period, 2023 – 2031. The growth of the market is attributed to increasing accidents and road injuries and the rising incidence of disabilities and organ failure. Furthermore, the technological advancements and the increasing healthcare expenditure in the region are boosting the market growth.

Artificial organs and bionics refers to man-made devices that can be integrated or implanted into humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to sustain a normal life.

UAE Artificial Organs & Bionic Implants Market Outlook

As per Dubai Health Authority (DHA), 2019, UAE has high prevalence of diabetes; the prevalence of diabetes is anticipated to rise to more than 21.5%. The key factors responsible for the amputations are due to diabetic foot ulcers. More than half of all foot ulcers (wounds) are expected to become infected, requiring hospitalization, and 20% of infections were expected to result in amputation.

The Covid-19 pandemic had a positive impact on the UAE artificial organs & bionic implants market. According to World Health Organisation (WHO) the Covid-19 pandemic has impacted and surged the demand artificial organs & bionic implants. It has generated immense opportunity for the market. Also government’s support in developing such technologies is expected to boost the global market of UAE artificial organs & bionic implants.

  • Growing incidence of organ failure and disabilities are expected to drive the market during the forecast period.

  • Increasing number of accidents and road injuries are estimated to propel the market in coming years.

  • Rising prevalence of diabetes among population is likely to surge the artificial organs & bionic implants market.

  • High cost associated with organs and the procedures are expected to impede the market.

  • Fear of device malfunction and its consequences is hindering the artificial organs and bionic implants market in the country.

  • R&D investment and technological advancement in the UAE artificial organs & bionic implants market are expected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the UAE artificial organs & bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

UAE Artificial Organs & Bionic Implants Market –Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016

Forecast Period

2023–2031

Segmentation

Product (Artificial Organs [Artificial Heart, Artificial Kidney, Cochlear Implants, and Others], Bionics [Vision Bionics, Ear Bionics, Orthopedic Bionic, Cardiac Bionics, and Others])

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Boston Scientific Corporation; Medtronic plc; Zimmer Biomet; Otto Bock Holding GmbH & Co. KG; and Edwards Lifesciences Corporation.

 

Market Segment insights

The orthopedic bionic segment is projected to constitute a large market share

Based on product, the artificial organs & bionic implants market is segregated into artificial organs, bionics. The artificial organ segment is further divided into artificial heart, artificial kidney, cochlear implants, and others and the bionics segment is further divided into vision bionics, ear bionics, orthopedic bionic, cardiac bionics, and others. The orthopedic bionic segment is expected to account for a key share of the market during the forecast period owing to increasing prevalence of road accidents and injuries, which is increasing the demand for artificial limbs and other bionics. Furthermore, increasing geriatric population who are in need of total joints replacement and knee replacement is also fueling the segment growth.

UAE Artificial Organs & Bionic Implants Market Product

Segments

The UAE artificial organs & bionic implants market has been segmented on the basis of:-

Product

  • Artificial Organs
    • Artificial Heart
    • Artificial Kidney
    • Cochlear Implants
    • Others
  • Bionics
    • Vision Bionics
    • Ear Bionics
    • Orthopedic Bionic
    • Cardiac Bionics
    • Others

Key Companies

  • Boston Scientific Corporation
  • Medtronic plc
  • Zimmer Biomet
  • Otto Bock Holding GmbH & Co. KG
  • Edwards Lifesciences Corporation

Competitive Landscape

Key players competing in the UAE artificial organs & bionic implants market include Boston Scientific Corporation; Medtronic plc; Zimmer Biomet; Otto Bock Holding GmbH & Co. KG; and Edwards Lifesciences Corporation.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.

UAE Artificial Organs & Bionic Implants Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs & Bionic Implants Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Artificial Organs & Bionic Implants Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Artificial Organs & Bionic Implants Market - Supply Chain
  4.5. Global Artificial Organs & Bionic Implants Market Forecast
     4.5.1. Artificial Organs & Bionic Implants Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Artificial Organs & Bionic Implants Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Artificial Organs & Bionic Implants Market Absolute $ Opportunity
5. Global Artificial Organs & Bionic Implants Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
     5.3.1. Boston Scientific Corporation
     5.3.2. Medtronic plc
     5.3.3. Zimmer Biomet
     5.3.4. Otto Bock Holding GmbH & Co. KG
     5.3.5. Edwards Lifesciences Corporation
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Artificial Organs & Bionic Implants Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Artificial Organs & Bionic Implants Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
7. North America Artificial Organs & Bionic Implants Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
     7.4.1. Boston Scientific Corporation
     7.4.2. Medtronic plc
     7.4.3. Zimmer Biomet
     7.4.4. Otto Bock Holding GmbH & Co. KG
     7.4.5. Edwards Lifesciences Corporation
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
8. Latin America Artificial Organs & Bionic Implants Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
     8.4.1. Boston Scientific Corporation
     8.4.2. Medtronic plc
     8.4.3. Zimmer Biomet
     8.4.4. Otto Bock Holding GmbH & Co. KG
     8.4.5. Edwards Lifesciences Corporation
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
9. Europe Artificial Organs & Bionic Implants Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
     9.4.1. Boston Scientific Corporation
     9.4.2. Medtronic plc
     9.4.3. Zimmer Biomet
     9.4.4. Otto Bock Holding GmbH & Co. KG
     9.4.5. Edwards Lifesciences Corporation
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
10. Asia Pacific Artificial Organs & Bionic Implants Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
     10.4.1. Boston Scientific Corporation
     10.4.2. Medtronic plc
     10.4.3. Zimmer Biomet
     10.4.4. Otto Bock Holding GmbH & Co. KG
     10.4.5. Edwards Lifesciences Corporation
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
11. Middle East & Africa Artificial Organs & Bionic Implants Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
     11.4.1. Boston Scientific Corporation
     11.4.2. Medtronic plc
     11.4.3. Zimmer Biomet
     11.4.4. Otto Bock Holding GmbH & Co. KG
     11.4.5. Edwards Lifesciences Corporation
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Artificial Organs & Bionic Implants Market: Market Share Analysis
  12.2. Artificial Organs & Bionic Implants Distributors and Customers
  12.3. Artificial Organs & Bionic Implants Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Methodology

Our Clients

Pfizer
FedEx Logistics
Deloitte
Microsoft
Siemens Healthcare
General Mills
sinopec
Nestle SA